February 29, 2024

Orbis Medicines Launches with €26 Million Seed Financing to Transform Macrocycle Drug Development through Next-Generation Orally Dosable ‘nCycles’

Orbis Medicines

Investment raised

EUR 26M

Valuation

Stage

Region

Investors

Forbion Capital Partners (https://forbion.com/en/) Novo Holdings (https://novoholdings.dk/)